27 FEB 2019 | DARMSTADT, GERMANY $48 Per Share Proposal Represents a Premium to Current Value of Entegris’ All-stock Proposal Merck KGaA, Darmstadt, Germany, a leading science and technology company, today delivered a letter to the Board of Directors of Versum Materials, Inc. (“Versum”), outlining the terms of a superior proposal to acquire Versum for $48 per share... Read more
Shimadzu’s LCMS-9030 quadrupole time-of-flight mass spectrometer has been awarded an iF DESIGN AWARD 2019. The iF DESIGN AWARD, which has been conferred by iF International Forum Design GmbH since 1953, is a prestigious international design award. On this occasion, there were 6,375 entries from 52 countries. The Shimadzu LCMS-9030 won in the Industry/Tools category. Previous... Read more
February 26, 2019 Shimadzu Corporation has released the Nexis SCD-2030 sulfur chemiluminescence detection system. This system consists of a Nexis GC-2030 high-performance gas chromatograph and the newly developed SCD-2030 sulfur chemiluminescence detector. With the release of the Nexis SCD-2030, which achieves the world’s highest level of sensitivity and offers excellent operability, maintainability, and stability, Shimadzu... Read more
Thermo Fisher Scientific to Support mRNA-based Vaccine Candidate Production for BioNTech Agreement ensures consistent supply of nucleotides, enzymes and other critical raw materials for messenger RNA (mRNA) vaccine manufacturing platform WALTHAM, Mass., Feb. 26, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has signed a multi-year agreement with Mainz,... Read more
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives Expanded Regulatory Approval in Japan Companion diagnostic test enables physicians to identify non-small cell lung cancer patients who may benefit from eight targeted therapies CARLSBAD, Calif., Feb. 26, 2019 /PRNewswire/ — Thermo Fisher Scientific today announced that the Ministry of Health, Labour and Welfare (MHLW), Japan’s regulatory agency,... Read more
BILLERICA, Mass., Feb. 25, 2019 /PRNewswire/ — Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following conferences: 8th Annual SVB Leerink Healthcare Conference, New York, NYThursday, February 28, 2019, at 10:30 a.m. Eastern TimeFrank Laukien, Chairman, President and Chief Executive Officer Cowen 39th Annual Health Care Conference, Boston, MATuesday, March 12, 2019, at... Read more
Medical and dental facilities, nuclear power plants and other sites can now simplify their radiation safety program by accessing dosimetry technology and services from single provider TEWKSBURY, Mass., Feb. 25, 2019 /PRNewswire/ — A new dosimetry monitoring service from Thermo Fisher Scientific enables medical and imaging facilities, dental offices, veterinary clinics, nuclear power plants, laboratories and... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 22, 2019– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen and Company 39th Annual Health Care Conference onMonday, March 11, 2019, at 1:30 p.m. ET at the Marriott Copley Place in Boston. Prahlad Singh, PerkinElmer’s president... Read more
Agilent Presents Thought Leader Award to Professor Diether Lambrechts Belgian scientist recognized for his research in cancer genomics SANTA CLARA, Calif., February 20, 2019 Agilent Technologies Inc. (NYSE: A) today announced that Professor Diether Lambrechts has received an Agilent Thought Leader Award in support of his research in cancer genomics. Dr. Lambrechts directs the VIB-KU... Read more
19 FEB 2019 | DARMSTADT, GERMANY Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions of the genome, increasing genome coverage Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in genome editing, today announced that the United States Patent and Trademark Office has issued... Read more